Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors

Transfusion

Volumn 53, Issue 6, 2013, Pages 1240-1249

  Wang, Jingxing ^a   Liu, Jing ^a   Yao, Fuzhu ^a   Wen, Guoxin ^a   Li, Julin ^a   Huang, Yi ^a   Lü, Yunlai ^a   Wen, Xiuqiong ^a   Wright, David ^a   Yu, Qilu ^a   Guo, Nan ^a   Ness, Paul ^a   Shan, Hua ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CHINESE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; TORQUE TENO VIRUS INFECTION; WESTERN BLOTTING;

EID: 84878948676     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03940.x     Document Type: Article

References (30)

1. Ministry of Health of China, UNAIDS, WHO. 2009 estimates for the HIV/AIDS epidemic in China. Beijing: Ministry of Health, May 2010. [cited 2012 May 1]. Available from: URL: http://www.unaids.org.cn/download/ 2009%20China%20Estimation%20Report-En.pdf
2. Wang N, Wang L, Wu Z, Guo W, Sun X, Poundstone K, Wang Y,; the National Expert Group on HIV/AIDS Estimation. 2010. Estimating the number of people living with HIV/AIDS in China: 2003-09.
3. Ministry of Health of People's Republic of China. China 2010 UNGASS country progress report (2008-2009). April 2010. [cited 2012 May 1]. Available from: URL: http://www.unaids.org/fr/dataanalysis/monitoringcountryprogress/ 2010progressreportssubmittedbycountries/file,33645,fr.pdf
4. World Health Organization. Blood safety. Fact Sheet No. 279, June 2011. [cited 2012 May 10]. Available from: URL: http://www.who.int/worldblooddonorday/ media/who-blood-safety-factsheet-2011.pdf
5. Xiao Y, Ding X, Li C, Liu J, Sun J, Jia Y,. Prevalence and correlates of HIV and syphilis infections among men who have sex with men in Chongqing Municipality, China. Sex Transm Dis 2009; 36: 647-656.
6. Zhang Y, Chen P, Lu R, Liu L, Wu Y, Zhao Z, Yi D,. Prevalence of HIV among men who have sex with men in Chongqing, China, 2006-2009: cross-sectional biological and behavioral surveys. Sex Transm Infect 2012; 88: 444-450.
7. Ministry of Health of People's Republic of China. Chinese health statistical digest, reported incidence & death rate of 28 infectious diseases in 2010. Center for Statistics Information, MOH, 2011. [cited 2012 May 1]. Available from: URL: http://www.moh.gov.cn/publicfiles/business/htmlfiles/ zwgkzt/ptjty/digest2010/index.html
8. Wang J, Guo N, Guo X, Li J, Wen GX, Yang T, Yun Z, Huang Y, Schreiber GB, Kavounis K, Ness P, Shan H,. Who donates blood at five ethnically and geographically diverse blood centers in China in 2008. Transfusion 2010; 50: 2686-2694.
9. Dodd RY, Notari EP IV, Stramer SL,. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-979.
10. Glynn SA, Kleinman SH, Wright DJ, Busch MP,. International application of the incidence rate/window period model. Transfusion 2002; 42: 966-972.
11. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP,. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280: 42-48.
12. Chinese Ministry of Health. Technical and operational guidelines and procedures for blood centers, December 31, 2011. [cited 2012 Jun 1]. Available from: URL: http://www.gov.cn/gzdt/2012-02/28/content-2078097.htm
13. Liu GF, Wang J, Liu K, Snavely DB,. Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials. Stat Med 2006; 25: 1275-1286.
14. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR,. Time course of detection of viral and serologic markers preceding humanimmunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-97.
15. UNAIDS. Global facts and figures, 2009. [cited 2012 Jun 1]. Available from: URL: http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/ factsheet/2009/20091124-fs-global-en.pdf
16. Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, Lin LS, An Q, Mermin J, Lansky A, Hall HI,; HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. Plos ONE 2011; 6: e17502.
17. Gill B, Huang Y, Lu X,. Demography of HIV/AIDS in China. Washington (DC): Center for Strategic and International Studies; 2007.
18. Qiu J,. China. Stigma of HIV imperils hard-won strides in saving lives. Science 2011; 332: 1253-1254.
19. Burki TK,. Discrimination against people with HIV persists in China. Lancet 2011; 377: 286-287.
20. Chen KT, Qian HZ,. Mother to child transmission of HIV in China. BMJ 2005; 330: 1282-1283.
21. Ministry of Health of China, UNAIDS, WHO. 2005 update on the HIV/AIDS epidemic and response in China. Beijing: Ministry of Health; 2006. [cited 2012 May 1]. Available from: URL: http://data.unaids.org/publications/External- Documents/rp-2005chinaestimation-25jan06-en.pdf
22. O'Brien SF, Yi QL, Fan W, Scalia V, Fearon MA, Allain JP,. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang 2012; 103: 83-86.
23. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC,. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007; 47: 316-325.
24. Lefrere JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, Tapko JB, Murphy EL, Laperche S, Pillionel J,. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 2011; 51: 486-492.
25. Sabino EC, Gonçalez TT, Carneiro-Proietti AB, Sarr M, Ferreira JE, Sampaio DA, Salles NA, Wright DJ, Custer B, Busch M,. Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil. Transfusion 2012; 52: 870-879.
26. Zeng P, Wang J, Huang Y, Guo X, Li J, Wen G, Yang T, Yun Z, He M, Liu Y, Yuan Y, Schulmann J, Glynn S, Ness P, Jackson JB, Shan H,; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers. Transfusion 2012; 52: 1041-1049.
27. Tu YQ, Wang MJ, Yao J, Zhu XM, Pan PL, Xing WG, Zhang GH, Yang RG, Zheng YT, Jiang Y,. Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China. Transfusion 2009; 49: 1865-1873.
28. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH,; NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-264.
29. Yu X, Huang Y, Qu G, Xu J, Hui S,. Safety and current status of blood transfusion in China. Lancet 2010; 375: 1420-1421.
30. National Center for AIDS/STD Control and Prevention, Chinese CDC. A clinical evaluation of the anti-HIV diagnostic assays in China in 2010 (in Chinese), January 2011. [cited 2012 Jul 30]. Available from: URL: http://www.chinaids.org.cn/n16/n1193/n4073/557057.html